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1. Introduction 
It has been suggested that cell-free preparations 
from brain tissue are unable to convert mevalonic 
acid into sterols because of a metabolic block between 
squalene and desmosterol [1, 2]. Such a block could 
result either from the presence of an inhibitor sub- 
stance or from an enzyme instability [2]. This pres- 
ent study demonstrates that microsomal fractions 
from brains of immature rats are capable of con- 
verting squalene into sterols in vitro but that the con- 
version requires the 100,000 g supernatant fraction 
from liver. It is suggested that the 100,000 g super- 
natant fraction from brain lacks an activator similar 
to that present in the liver fraction, and that this 
deficiency is responsible for inability of brain frac- 
tions to convert squalene into sterols. The possibility 
that an inhibitor is present in the brain microsomal 
fraction is ruled out by the data presented. 
2. Materials and methods 
DL-2-14C-mevalonic a id as the dibenzylethylene- 
diamine salt (specific activity 12.5 mCi/mmole) was 
purchased from New England Nuclear Corp., Boston, 
Mass. ~4C-Squalene was prepared by the method of 
Tchen [3] and purified on alumina column. 
Brains and livers were obtained from Sprague- 
Dawley rats which were 5-12 days old. The tissues 
were homogenized in 3 vol of 0.02 M phosphate buffer 
pH 7.4 containing 0.1 mM EDTA. Homogenates 
were centrifuged at 800 g for 10 min to prepare an 
North.Holland Publishing Company - Amsterdam 
800g supernatant ($1), at 18,000g for 20 min to 
prepare an 18,000 g supernatant ($2), and at 
100,000 g for 60 min to prepare a 100,000 g super- 
natant ($3). The microsomal pellet (MS) which re- 
mained after centrifugation at 100,000 g was re- 
suspended in a volume of the phosphate buffer equal 
to that of the tissue homogenate. The various frac- 
tions were incubated with 14C-squalene for 2 hr in 
an atmosphere of 95% 02 and 5% CO2 at 37 °. Other 
details of the incubations are given in the legend to 
table 1. Incubations were terminated by addition of 
15% KOH in 50% ethanol. The contents of the flask 
were saponified, and nonsaponifiable lipids were 
extracted from the saponification mixtures by light 
petroleum. 3/3-Hydroxysterols were precipitated as 
digitonides. An aliquot of the light-petroleum frac- 
tions was evaporated to dryness, and the residue was 
then dissolved in 3 ml of acetone-ethanol (1:1) con- 
taining unlabeled lanosterol and cholesterol. The 
sterols were precipitated from the solvent with 7 ml 
of 0.5% digitonin in 50% ethanol. Digitonides were 
recovered by centrifugation and washed as described 
elsewhere [4]. Sterols were separated by thin layer 
chromatography (TLC) on precoated silica gel film 
using benzene:ethylacetate 95:5 as developing sol- 
vent. The 14C content in the nonsaponifiable lipids, 
digitonin precipitable sterols and the TLC spots 
were determined in a liquid scintillation counter. 
3. Results 
The radioactivity scan obtained after extraction 
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Fig. 1. Separation of squalene and sterols by thin layer chromatography, The incubation conditions were as in table 1, A) Radio- 
activity scan of the nonsaponifiable lipid extract obtained from a zero-time control sample for 800 g supernatant from liver. 
B) Radioactive scan of the lipid extract obtained after incubation of squalene, with 1 ml of 800 g supernatant fraction from brain. 
C) Radioactive scan of the lipid extract obtained after incubation of squalene with 1 ml of 800 g supernatant fraction from liver. 
of nonsaponifiable lipids, and separation of squalene 
and sterols by TLC (fig. 1) shows that little con- 
version of squalene into sterols occurred when 
squalene was incubated with 1 ml of the 800 g super- 
natant from brain (fig. 1B). However, the incubation 
of squalene with 1 ml of the 800 g supernatant from 
liver showed a significant conversion i to sterols, 
principally cholesterol (fig. 1C). The data in table 1, 
obtained from a representative experiment gives the 
quantitative distribution of 14C after incubation of 
labeled squalene with combination of various tissue 
fractions. After incubation of squalene with 0.5 ml 
of the 800 g supernatant from brain, 0.68% of the 
label was recovered in lanosterol and 0.64% in the 
cholesterol fraction. When 0,5 ml of the 800 g super- 
natant from liver was substituted for the brain frac- 
tion, 1,95% and 6.32% of the label was recovered 
in lanosterol and cholesterol fractions, respectively. 
A corresponding difference between the 2 tissue 
fractions was also seen in the percent 14C recovered 
as digitonin precipitable sterols. When squalene was 
incubated with combined 800 g supematant frac- 
tions from brain (0.5 rot) and liver (0.5 ml), the 
percentage of 14C recovered in the sterol fraction 
was significantly higher than what would be expected 
from incubation of squalene with the 2 fractions 
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Table 1 
Conversion of squalene into sterols by cell-free preparations from brain and livers of developing rats. 
January 1972 
Cell fraction 14C Recovered (% of total) 
incubated Digitonin Lanosterol Cholesterol 
precipitable fraction fraction 
sterols 
$1 B(0.5 ml) 0.87 0.68 0.64 
$1 B(1.0 ml) 1.02 1.08 0.62 
$1 L(0.5 ml) 6.76 1.95 6.32 
S1 L(1.0 ml) 10.6 2.70 9.83 
$1 B (0.5 ml) + $1 L (0.5 ml) 10.3 2.81 10.9 
$2 B (1.0 ml) 0.65 1.07 0.55 
$2 L (1.0 ml) 10.0 2.35 7.64 
MS B (1.0 ml) 0.36 0.36 0.40 
MS B (1.0 ml) + $3 B (1.0 ml) 0.61 0.86 0.53 
MS B (1.0 ml) + S a L (1.0 ml) 7.55 6.62 1.21 
$3 B (1.0 ml) 0.34 0.31 0.48 
MS L (1.0 ml) 1.16 0.51 1.04 
MS L (1.0 ml) + S 3 L (1.0 ml) 15.3 1.90 14.2 
MS L (1.0 ml) + S 3 B (1.0 ml) 1.32 1.00 1.20 
S 3 L (1.0 ml) 0.24 0.35 0.30 
14C-Squalene (25,000 cpm) was incubated with various cell fractions as indicated. Sl, 800 g supernatant; $2, 18,000 g super- 
natant; $3, 100,000 g supernatant; MS, microsomal pellet 18,000-100,000 g; B, fractions obtained from brain homogenate; 
L, fractions obtained from liver homogenate. The final vol of 2.5 ml of the incubation mixture was made up by the addition 
of the phosphate-EDTA buffer (see Materials and methods for details). Each incubation contained 3umoles NADPH, 1.5 ~moles 
NAD, 60/~moles nicotinamide, 10 ~moles glucose 6-PO 4 and 1 unit glucose 6-PO 4 dehydrogenase. All values are the average of 
closely agreeing duplicate determinations. 
alone. This result would rule out the presence of an 
inhibitory substance in the cell-free preparations 
from brain, and would suggest that preparations 
from liver contain a factor(s) which enhanqes the 
conversion of squalene into sterols by brain fractions. 
Incubation of labeled squalene with subcellular 
fractions from brain and liver yielded results which 
support he above suggestion. When squalene was 
incubated with a combination of brain microsomes 
and liver 100,000 g supexnatant, there was significant 
conversion of squalene into sterols (6.62% in lano, 
sterol and 1.21% in cholesterol). However, little con- 
version took place when squalene was incubated with 
brain microsomes alone (0.36% in lanosterol and 
0.40% in cholesterol) or in combination with the 
100,000 g supernatant from brain (0.86% in lano- 
sterol and 0.53% in cholesterol). This enhanced con- 
version of squalene into sterols by brain microsomes 
in the presence of liver supernatant is also reflected 
in an approx. 10-fold increase in the percent 14C 
recovered in digitonin precipitable sterols, over that 
which was recovered when brain supernatant replaced 
liver supernatant. The negligible conversion of 
squalene into sterols by the liver 100,000 g super- 
natant indicates that the fraction is enzymatically 
inactive. The data in table 1 also show that 100,000 
g supernatant from brain tissue does not significantly 
enhance the conversion by liver microsomes of 
squalene into sterols. By contrast, squalene is con- 
verted into sterols by liver microsomes in the pres- 
ence of liver 100,000 g supernatant. 
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4. Discussion 
The conversion in vitro of squalene into cholesterol 
by washed microsomal fractions from liver requires 
the addition of I00,000 g supernatant fluid. The 
supernatant fraction has no enzyme activity but is 
thought o contain a protein which acts as a carrier 
[5] or activator [6, 7] of the precursors for choles- 
terol. The results of the present study demonstrate 
that brain microsemal fractions, either alone or in 
combination with 100,000 g supernatant from brain, 
are unable to convert squalene into sterols efficiently. 
However, when 100,000 g supernatant from liver is 
substituted for the supernatant fraction from brain, 
the conversion of squalene into sterols by brain mi- 
crosomes is markedly enhanced. This indicates that 
liver supernatant can serve as an activator for squalene 
metabolism by brain microsomes. The fact that the 
100,000 g supernatant from brain had no effect on 
the conversion of squalene into sterols by liver micro- 
somes indicates that there is a deficiency of an acti- 
vator in this fraction. 
It was previously shown that brain desmosterol 
reductase is primarily a particulate bound enzyme, 
and that the activity of this enzyme is not enhanced 
by 100,000 g supernatant fraction from brain [8]. 
These results further support he contention that 
the brain fraction lacks an activator substance. The 
low incorporation of ~4C from mevalonic acid into 
digitonin precipitable sterols by cell-free preparations 
from brain [ 1, 2] can also be explained by such a 
deficiency. 
It is concluded that cerebral microsomal fractions 
contain an active enzyme system for converting 
squalene into sterols, but that an apparent block in 
the in vitro conversion is caused by a deficiency of 
an activator or carrier protein in 100,000 g brain 
supernatant fraction. 
Acknowledgements 
This investigation was supported by grants from 
the National Institutes of Health No. HD-01823 and 
NS-09301. The expert echnical assistance of Mr. 
John McKay is gratefully acknowledged. 
References 
[1] S.N. Shah, Proc. Third Intern. Meeting Intern. Soc. 
Neurochem., Budapest, Hungary (1971) Abst. 373. 
[2] R.B. Ramsey, J.P. Jones, S.H.M. Naqvi and H.J. Nicholas, 
Lipids 6 (1971) 154. 
[3] T.T. Tchen, Methods in Enzymology, Vol. VI, eds. 
S.P. Colowich and N.O. Kaplan (Academic Press, New 
York and London, 1963) p. 509. 
[4] S.N. Shah, N.A. Peterson and C.M. McKean, Biochem. 
Biophys. Acta 187 (1969) 236. 
[5] T.J. Scallen, M.W. Schuster and A.K. Dhar, J. Biol. 
Chem. 246 (1971) 224. 
[6] M.C. Ritter and M.E. Dempsey, J. Biol. Chem. 246 
(1971) 1536. 
[7] M.C. Ritter and M.E. Dempsey, Biochem. Biophys. Res. 
Commun. 38 (1970) 921. 
[8] C.M. Hinse and S.N. Shah, J. Neurochem. 18 (1971) 
1989. 
78 
